Boarfish (<i>Capros aper</i>) protein hydrolysate has potent insulinotropic and <scp>GLP</scp>‐1 secretory activity <i>in vitro</i> and acute glucose lowering effects in mice

Vadivel Parthsarathy, C. McLaughlin, Pádraigín A. Harnedy, Philip J. Allsopp, William Crowe, Emeir M. McSorley, Richard J. Fitzgerald, Finbarr O’Harte

International Journal of Food Science & Technology · 2018 · 35 citations · 43 references

DOIFull text

Open access

Concepts

Abstract

Summary The anti‐diabetic actions of a boarfish protein hydrolysate ( BPH ) were investigated in cultured cells and mice. A boarfish ( Capros aper ) muscle protein hydrolysate was generated using the enzymes Alcalase 2.4 L and Flavourzyme 500 L. Furthermore, the BPH was subjected to simulated gastrointestinal digestion ( SGID ). BPH and SGID samples (0.01–2.5 mg mL −1 ) were tested in vitro for DPP ‐ IV inhibition and insulin and GLP ‐1 secretory activity from BRIN ‐ BD 11 and GLUT ag cells, respectively. The BPH and SGID samples, caused a dose‐dependent increase (4.2 to 5.3‐fold, P &lt; 0.001) in insulin secretion from BRIN ‐ BD 11 cells and inhibited DPP ‐ IV activity ( IC 50 1.18 ± 0.04 and 1.21 ± 0.04 mg mL −1 ), respectively. The SGID sample produced a 1.3‐fold ( P &lt; 0.01) increase in GLP ‐1 secretion. An oral glucose tolerance test ( OGTT ) was conducted in healthy mice ( n = 8), with or without BPH (50 mg/kg bodyweight). BPH mediated an increase in plasma insulin levels ( AUC (0–120 min), P &lt; 0.05) and a consequent reduction in blood glucose concentration ( P &lt; 0.01), after OGTT in mice versus controls. The BPH showed potent anti‐diabetic actions in cells and improved glucose tolerance in mice.

References

43